Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Suppressing eIF4E can prevent hair loss from chemotherapy.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Future acne treatments should aggressively target inflammation to prevent scarring.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Some drugs used to treat immune conditions may cause different types of hair loss.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

The document concluded that stem cells are crucial for skin repair, regeneration, and may help in developing advanced skin substitutes.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Tumor proteins can both promote and suppress cancer, depending on the situation.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The extracellular matrix is crucial for controlling skin stem cell behavior and health.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.